The IPSS-del(5q): a newly developed prognostic score for MDS with isolated 5q deletion

(1:2)

The influence of TP53 mutations in MDS with isolated 5q deletion

(52)

5q Minus Syndrome: What we know (and what we don't know yet)

(22:59)

5Q with Jess Greenwood / R/GA

(5:57)

When to use lenalidomide in MDS patients with and without deletion 5q

(4:21)

Management of treatment-naïve LR-MDS with isolated 5q deletion (del5q)

(14:50)

Transplantation and Deletion 5q Syndrome: A Case Example

(3:7)

Living with MDS 5Q Deletion, Myelodysplastic Syndrome, Ann’s Story, A Patient’s Perspective

(6:55)

SINTRA-REV update: early lenalidomide treatment in non-transfusion dependent del(5q) LR-MDS

(1:15)

Considering Lenalidomide in Non-Del 5q MDS

(7:56)

Choosing Lenalidomide vs ESAs in Del 5q MDS

(6:31)

5Q with ABJ @kincadeskylar@htw_network

(1:)

5Q with ABJ @jaytrain40@htw_network @newerapwhttps://youtu.be/EWRsU2lCHqM?si=6cZWYPZWr5yMWnAo

(21)

5Q with ABJ @the_ace_austin@htw_network @newerapwhttps://youtu.be/YwSUXvG6Ej0?si=_-oFkhX0avKr7eSe

(53)

5Q with ABJ Dr Frank@htw_network

(24)

5Q With ABJ NCIHS @witchcraftsbylilly @lillyrayne1213@htw_network

(1:)

Lenalidomide in Del 5q MDS

(8:7)

5Q with ABJ @brianborcky

(59)

Out Now⚠️ 5Q with ABJ with @ultramantis.blackhttps://youtu.be/r9km5x-TKxQ

(48)

5Q with ABJ Dr Frank@htw_network

(18)